Dr. Xiaoxia Nina Lin is Co-Founder and Scientific Advisor at Ecovia Bio, a biotechnology company developing biodegradable biopolymers to replace harmful plastics. The company produces gamma polyglutamic acid based materials for cosmetics, personal care, agriculture, and hygiene applications.

Dr. Lin earned her PhD in Chemical Engineering from Princeton University and completed a postdoctoral fellowship at Harvard Medical School. She is a Professor of Chemical and Biomedical Engineering at the University of Michigan, where her research focuses on engineering synthetic microbial communities using systems biology and synthetic biology approaches.

Dr. Lin received an NSF CAREER award in 2011 and has secured funding from NSF, NIH, and USDA for her pioneering research on microbial ecosystems. She holds dual bachelor's degrees in Chemical Engineering and Computer Science from Tsinghua University.

Ecovia Bio has raised over $13M in total funding, including a recent Series B round led by Pointe Angels. The company spun out from the University of Michigan in 2014 and has secured partnerships with companies like Seppic (Air Liquide subsidiary).

Ecovia Bio is expanding its Livonia, Michigan manufacturing facility to achieve full operational capacity by 2028. The company's AzuraBase and AzuraGel biopolymer products serve global customers across multiple industries, providing biodegradable alternatives to petrochemical-based plastics.